Overview

Phase II Trial of SK3530 in Erectile Dysfunction

Status:
Terminated

Trial end date:
2005-03-01

Target enrollment:

Participant gender:

Summary

This study was designed to evaluate the efficacy and safety of the SK3530 tablet and to find the optimal dose and dosage schedule after oral administration to patients with erectile dysfunction.

Phase:

Phase 2

Details

Lead Sponsor:

SK Chemicals Co., Ltd.
SK Chemicals Co.,Ltd.